Navigation Links
NextGen introduces its first generation of animal biomarker products for development of brain disorder diagnostics
Date:6/15/2012

LONDON and ANN ARBOR, Mich., June 15, 2012 /PRNewswire/ -- NextGen Group Plc (AIM: NGG), the AIM listed company developing its own diagnostics product pipeline and providing diagnostic biomarker development services, announces the commercialisation of a new assay for the identification of diagnostic biomarkers in brain disorders in animal models.

The assay measures protein markers in rat cerebrospinal fluid and will expand the product offering of NextGen's contract research subsidiary, NextGen Sciences Inc.

An assay is the procedure for measuring the effects of a chemical in an organism. For example, assays are used to discover biomarkers which are in turn used to identify the existence and progression of a disease. Biomarkers are used in clinical trials to aid in patient selection and to evaluate the effectiveness of a drug. They are also used in the development of companion diagnostics that will drive the growth of the personalised medicine market.

There is a significant need for biomarkers to monitor and diagnose central nervous system disorders, such as dementia, Parkinson's disease and neuropsychological disorders, within the patient care and drug development industries.

NextGen's "CSFassay-rat A.1.0" product is capable of measuring 62 cerebrospinal fluid (CSF) proteins simultaneously that have been identified as likely biomarkers in various central nervous system (CNS) disorders.

Barry McAleer, PhD, CEO of NextGen Sciences Inc says: "Assays that can discover biomarkers in animal models will enhance the drug development process within the pharmaceutical industry and could lead to reduced attrition in the drug development process. With the introduction of the CSFassay-rat A.1.0 we have delivered on the first phase of ongoing product development plans that enables us to support and enhance the pre-clinical drug development programs of our customers. This new product and those currently in development are already attracting i
'/>"/>

SOURCE NextGen Sciences
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
2. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
3. New England Biolabs Introduces Polbase, an Information Repository of Scientific Data for Polymerase Researchers
4. CU-Boulder physicists use ultrafast lasers to create first tabletop X-ray device
5. First experiment at the ALBA synchrotron
6. EPSRC announces first recipients of Fellowships in Manufacturing
7. GeneLink Reports First Quarter 2012 Financial Results
8. Diversionary Therapy Announces First Sale of ditto™ dental
9. Cord Blood America Announces First Quarter Financial Results
10. Vermillion Reports First Quarter 2012 Results
11. Cardium Presents First Quarter 2012 Financial Results and Recent Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 05, 2015 Hayden-McNeil is ... develop custom course materials for smaller courses. This program ... low as 200 students. , “I’m very excited ... of higher education instructors,” said Jeff McCarthy, Hayden-McNeil president. ... can do our part to make education both more ...
(Date:5/5/2015)... , May 5, 2015  Renova™ Therapeutics, ... congestive heart failure and other chronic diseases, has ... independent analysis designed to reflect the healthcare patterns ... This model will be used to characterize the ... could have on those groups of patients and ...
(Date:5/5/2015)... Franz Inc ., the leading supplier of Semantic ... AllegroGraph, has been named a Champion by Bloor Research in ... AllegroGraph is a high performance Semantic Graph Database that enables ... skyrocketing in popularity and have grown by 400% in the ... by DB-Engines. , “We are excited that Graph and ...
(Date:5/5/2015)...   Tocagen Inc. , a clinical-stage immuno-oncology ... , M.D., a venture partner at New Enterprise ... of directors of Tocagen. Dr. Parkinson has more ... development, including leading clinical activities at Amgen and ... cancer therapeutics Gleevec®, Femara®, Zometa®, Kepivance® and Vectibix®, ...
Breaking Biology Technology:Hayden-McNeil Expands Publishing Program to Service Lower Enrollment Courses 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 3Bloor Research Positions AllegroGraph as a ‘Champion’ in Burgeoning Graph Database Market 2Bloor Research Positions AllegroGraph as a ‘Champion’ in Burgeoning Graph Database Market 3Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 2Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 3Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 4
... in 131.4% Increase in Revenue and Positive ... EBITDA for Three Consecutive Quarters, PRINCETON, ... development and protein production company, today,announced record growth in revenues ... period last year and generated positive EBITDA for,the third consecutive ...
... is so 2007. This,year scientists in North Carolina have ... Going Blue., This new charge is coming out ... country,s newest business incubators that,discovers, develops and markets new ... Blue initiative broadens the focus of environmental awareness,from land-based ...
... With Regional Perspective, PHILADELPHIA and LONDON, April ... information solutions to the worldwide,research and business communities, ... been added to Web of Science. The newly ... rather than,international audience by approaching subjects from a ...
Cached Biology Technology:Laureate Pharma Reports Record Growth for 2007 2Laureate Pharma Reports Record Growth for 2007 3When it Comes to Going Green, These N.C. Scientists are Singing the Blues 2Thomson Scientific Begins Expansion of Web of Science 2
(Date:4/9/2015)... JOSE, Calif. , April 9, 2015 ... human interface solutions, announced today that it will report ... on Thursday, April 23, 2015, after the close of ... for analysts and investors at 2:00 p.m. PT (5:00 ...   To participate on the live call, ...
(Date:4/2/2015)... -- At its 2015 ACMG Annual Clinical Genetics Meeting ... American College of Medical Genetics and Genomics (ACMG) announced ... Members of the ACMG Board of Directors serve as ... its policies and programs. ACMG is the national organization ... eventful time in medical genetics and genomics.  We are ...
(Date:4/1/2015)... Medisafe ™, the leading global medication management platform with ... Android smartphones and tablets, announces today that ... allow patients to track and correlate their adherence directly ... be able to visualize in real-time how taking medication ... glucose levels and blood pressure. "Patients need ...
Breaking Biology News(10 mins):Synaptics to Report Third Quarter Results on April 23 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2
... synthesis just published in Environmental Reviews reveals ... to address significant environmental, social and economic impacts of ... of climate change on the distribution of invasive alien ... prediction in a warming world" is the collaborative effort ...
... /PRNewswire-iReach/ -- Global Information Inc. (GII) is ... and networking events in the pharmaceuticals and biotechnology ... platform for researchers and decision makers in biotechnology ... learn about significant developments in the biotechnology and ...
... -- Fruit flies don,t have noses, but a huge part ... rely on the sense of smell more than any other ... danger. UW-Madison researchers have discovered that a gene called ... and respond to smells. As reported in the current ...
Cached Biology News:Climate change invites alien invaders Is Canada ready? 22012 Biotechnology and Pharmaceuticals: Forthcoming Conferences and Exhibitions 22012 Biotechnology and Pharmaceuticals: Forthcoming Conferences and Exhibitions 32012 Biotechnology and Pharmaceuticals: Forthcoming Conferences and Exhibitions 4Researchers find gene critical to sense of smell in fruit fly 2Researchers find gene critical to sense of smell in fruit fly 3
... based purification systems provide high speed purification ... They offer increased throughput and reproducible results. ... KingFisher mL and KingFisher 96, covering sample ... system consists of an instrument, specially designed ...
Candida (IgA) -Ab EIA Sample Size: 5 l...
... Principle: The Oxidized LDL Competitive ELISA ... LDL in the sample competes with a fixed ... well for the binding of the biotin- labeled ... 25 l The Oxidized LDL Competitive ...
OptiBuffer is a fully optimised medium, designed for,the electroporation of eukaryotic cells. OptiBuffer,improves both transfection efficiencies and survival,rates over PBS or other standard culture...
Biology Products: